Letter

My Third Letter to the APA Trustees

This letter was sent to the APA Trustees and to the DSM-5 Task Force on February 12, 2012, under the title, “Heads Up And Recommendations.”

Mapping hypofrontality during letter fluency task in schizophrenia: A multi-channel near-infrared spectroscopy study

Publication year: 2012Source: Schizophrenia Research, Available online 11 February 2012Shinji Shimodera, Yutaka Imai, Naoto Kamimura, Ippei Morokuma, Hirokazu Fujita, ...

[Correspondence] An open letter to Michael Ball, Chief Executive of Hospira Pharmaceuticals – Response from Hospira

Hospira shares the concern over improper use of our drugs in US executions. Hospira has long communicated that we do not support the use of any of our products in lethal injections—a use that is clearly outside the licensing approved by the Food and Drug Administration and completely counter to our company vision of advancing wellness. In fact, over the years, Hospira has regularly written to every US state to make clear that we oppose the use of our drugs, including pancuronium bromide, in executions, and we have stated our opposition publicly through the media innumerable times.

[Correspondence] An open letter to Michael Ball, Chief Executive of Hospira Pharmaceuticals

Earlier this year, your company determined that you could not prevent the diversion of the use of your company's product, thiopental, for use in capital punishment, so you stopped producing it completely. This resulted in US states that carry out the death penalty ultimately switching to pentobarbital, manufactured by Lundbeck. Lundbeck, initially, were hesitant to act, but, after a critical letter, took decisive action in the form of a restricted distribution system to tighten up their supply chain to ensure that pentobarbital was used only for legitimate clinical purposes.

U.S. Public Health Service Report Outlines Mechanisms to Encourage Advanced Pharmacy Practice

A new report released by U.S. Public Health Service provides a resource to advance beyond discussion of pharmacists in expanded roles and move toward implementation. The report has also earned support for the recognition of pharmacists as health care providers and clinicians. The report, Improving Patient and Health System Outcomes through Advanced Pharmacy Practice – A Report to the Surgeon General 2011, produced letters of support from prominent members of the medical community including the U.S. Surgeon General, Dr. Regina Benjamin, MD, MBA.

Patterns of new DNA letter in brain suggest distinct function

In 2009, the DNA alphabet expanded. Scientists discovered that an extra letter or "sixth nucleotide" was surprisingly abundant in DNA from stem cells and brain cells. Now, researchers have mapped the patterns formed by that letter in the brains of mice, observing how its pattern of distribution in the genome changes during development and aging.

This page may contain content contributed by CPNP members or aggregated from other online sources. This content is provided as an unmoderated service to members for civil discussion and collaboration. Any opinions, conclusions, or recommendations are those of the author. If you come across any abuse or violation of the terms of use, please report the abuse.